Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1
about
Oxidative stress responses and NRF2 in human leukaemiaAberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetRetinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cellsZinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.Ibrutinib inhibits SDF1/CXCR4 mediated migration in AMLRas/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells.Bortezomib induces heme oxygenase-1 expression in multiple myelomaHO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation.Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemiaLin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathwayCommon drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.Understanding the role of NRF2-regulated miRNAs in human malignancies.To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients.CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemiaRole of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.The short isoform of PML-RARα activates the NRF2/HO-1 pathway through a direct interaction with NRF2.Heme oxygenase-1 expression in the ovary dictates a proper oocyte ovulation, fertilization, and corpora lutea maintenance.Understanding life and death decisions in human leukaemias.Association between (GT)n Repeats in Heme Oxygenase-1 Gene Promoter and 3-Year Survival of Patients with Acute Leukemia: a Controlled, Cross-Sectional Study.
P2860
Q26864239-FCBE6134-7336-439E-84B8-B6541087615CQ26995561-CD9BD1AC-6EAB-40E8-95A8-4CB8606B69C7Q28393380-8A14356B-50E6-41A3-89D8-82F43821ED3FQ33887033-E986C2AA-54EE-4FD2-9A3D-57694CF877C3Q34042250-647BB299-E0C9-4E74-993F-A47B3C545C7AQ34307356-43A72377-E919-4777-A4F7-70708B5EB564Q35048614-FAB8500B-EA43-47A1-BB93-47EEA4032577Q36059668-6814042F-D846-48BD-8CFA-1974C77A73C3Q36336147-5CFA7870-AF8D-435D-9432-2E9DBA1ACBD9Q36646486-4430C7D0-EB92-4C60-814B-8AAB16B3FCD1Q36926129-D84445B2-B47F-4FC0-9FAB-F47C29B6CB7DQ36926139-2B1273E5-D497-4B0F-9DC3-BA90A04816FDQ36926148-41449B6E-65DC-488B-ABB1-BCB6925435C0Q37207646-3E7C748C-F2BA-4BFD-8162-90807D6BE224Q37225538-3A6A99DB-C648-4E41-9115-1C16B7462E7DQ37299309-C8BB5619-818A-4F6E-ABEF-5CCB4256EFE1Q37653706-EED602DA-D1A5-4807-AC8F-5D5653CED74DQ38809384-2DA3CEED-6247-40B3-9705-50D7D34E7B23Q38848661-C54C12C5-92F7-4AA1-BAA0-792C733DD040Q38869922-F21A0DDA-F6C9-4AAB-A855-811C928FB8CFQ39285687-598DF5BA-0A24-4E3C-A548-5B958FCB6F4FQ41874296-49EBFEEE-341A-4346-BFD2-55B1826B297FQ41882913-D7EFA124-2800-4049-AC27-7E2B2D08A0D2Q42546269-7D1686E4-CF6B-4A8A-84ED-16B3548FD0BDQ47990678-36F36C0F-2055-466D-8B40-F67585727E0AQ48660132-B07EA4A2-4EE4-471F-9F0E-B119317C2EF9Q55071953-12C404E1-CD69-45BF-A541-CEBB564C3C2EQ55366269-C6517047-4FF9-4896-A875-076A0558D0CA
P2860
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@ast
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@en
type
label
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@ast
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@en
prefLabel
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@ast
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@en
P2093
P2860
P356
P1433
P1476
Protection of acute myeloid le ...... s mediated by haem oxygenase-1
@en
P2093
David J Macewan
Kristian M Bowles
Lyubov Zaitseva
Sally-Anne Heasman
Stuart A Rushworth
P2860
P304
P356
10.18632/ONCOTARGET.321
P407
P577
2011-09-01T00:00:00Z